Treatment of hepatitis C virus genotype 4 in the DAA era

The recently approved interferon-free DAA (direct antiviral agents) regimens have shown not only to be effective in terms of sustained virological response (SVR) rates (> 90%) but also well tolerated in most hepatitis C virus (HCV) infected patients. Nevertheless HCV genotypes are different and o...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Biagio, Antonio, Taramasso, Lucia, Cenderello, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251143/
https://www.ncbi.nlm.nih.gov/pubmed/30466446
http://dx.doi.org/10.1186/s12985-018-1094-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251143/
https://www.ncbi.nlm.nih.gov/pubmed/30466446
http://dx.doi.org/10.1186/s12985-018-1094-4

Ejemplares similares